FDA Grants Breakthrough Therapy Tag to LLY's Ovarian Cancer Candidate — Positive

LLY   Zacks Investment Research — January 21, 2026

Eli Lilly wins FDA Breakthrough Therapy status for sofetabart mipitecan in certain patients with platinum-resistant ovarian cancer.

image for news FDA Grants Breakthrough Therapy Tag to LLY's Ovarian Cancer Candidate

Lululemon halts online sales of new collection after sheerness complaints — Negative

LULU   Proactive Investors — January 21, 2026

Lululemon Athletica Inc (NASDAQ:LULU) has temporarily paused online sales of its new Get Low activewear line after customers raised concerns that the fabric was too sheer. The collection, which includes leggings, tights, and tank tops designed to offer a sculpted, weightless feel during workouts, remains available in Lululemon's North American stores, according to a company spokesperson.

image for news Lululemon halts online sales of new collection after sheerness complaints

Can B&G Foods' Margin Improvement Hold Amid Soft Demand? — Positive

BGS   Zacks Investment Research — January 21, 2026

BGS sales dip in Q3, but steady EBITDA, cost cuts, and portfolio reshaping point to a higher-margin 2026.

image for news Can B&G Foods' Margin Improvement Hold Amid Soft Demand?

Ally Financial Inc. (ALLY) Q4 2025 Earnings Call Transcript — Neutral

ALLY   Seeking Alpha — January 21, 2026

Ally Financial Inc. (ALLY) Q4 2025 Earnings Call Transcript

image for news Ally Financial Inc. (ALLY) Q4 2025 Earnings Call Transcript

J&J Stock Down Despite Q4 Earnings Beat, Oncology Drugs Drive Sales — Neutral

JNJ   Zacks Investment Research — January 21, 2026

JNJ beat Q4 earnings and sales estimates as strong oncology drug growth, led by Darzalex, offset biosimilar pressure on Stelara.

image for news J&J Stock Down Despite Q4 Earnings Beat, Oncology Drugs Drive Sales

SIFCO Plunges 14.3% in the Past Three Months: How to Play the Stock? — Neutral

SIF   Zacks Investment Research — January 21, 2026

SIF's fourth-quarter fiscal 2025 results benefit from stronger margins and improved operations as aerospace demand and order backlog continue to build.

image for news SIFCO Plunges 14.3% in the Past Three Months: How to Play the Stock?

GE "Red, Red Hot:" Gauging Geopolitical Risk & Stock Rally Into Earnings — Positive

GE   Schwab Network — January 21, 2026

Geopolitical risk will drive GE Aerospace's (GE) upside potential "beyond the scope" of expectations, says Datavault AI CEO Nathaniel Bradley. He explains why investors should hold the stock long-term following its "rise and fall, and rise again.

image for news GE "Red, Red Hot:" Gauging Geopolitical Risk & Stock Rally Into Earnings

Xcel Energy a “World's Most Admired Company” for Twelfth Year — Neutral

XEL   Business Wire — January 21, 2026

MINNEAPOLIS--(BUSINESS WIRE)--For a twelfth year, Xcel Energy has been honored as one of the World's Most Admired Companies by Fortune magazine.

image for news Xcel Energy a “World's Most Admired Company” for Twelfth Year

XPO Named a World's Most Admired Company by Fortune — Neutral

XPO   GlobeNewsWire — January 21, 2026

GREENWICH, Conn., Jan. 21, 2026 (GLOBE NEWSWIRE) -- XPO (NYSE: XPO), a leading provider of freight transportation in North America, announced today that it has been named to Fortune's list of the World's Most Admired Companies for 2026.

image for news XPO Named a World's Most Admired Company by Fortune

ATLANTA, Jan. 21, 2026 /PRNewswire/ -- Southern Company has been named to FORTUNE's list of the World's Most Admired Companies for 2026, earning the No. 1 spot in the electric and gas utilities industry.

image for news Southern Company ranked No. 1 in industry on FORTUNE's 2026 World's Most Admired Companies list

Clorox Q2 Preview: Private Label Pressure Clouds The Outlook — Negative

CLX   Seeking Alpha — January 21, 2026

The Clorox Company is going to report its fiscal Q2 results soon. A shipment headwind and slowing consumption weigh on the quarter's outlook. The focus point is in CLX's outlook past Q2. The company guides growth reacceleration for H2, but growing private label penetration poses a clear threat. Weak growth is already priced in. I estimate CLX stock to have a fair value of $113.

image for news Clorox Q2 Preview: Private Label Pressure Clouds The Outlook

Grocery Outlet Reveals 2026 Xtreme Value™ Shopping Tips — Neutral

GO   GlobeNewsWire — January 21, 2026

EMERYVILLE, Calif., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Grocery Outlet Holding Corp. (NASDAQ: GO) ("Grocery Outlet" or the "Company"), today unveiled its top Food and Beverage Xtreme Value™ Tips for 2026, to help shoppers maximize savings while enjoying quality and variety.

image for news Grocery Outlet Reveals 2026 Xtreme Value™ Shopping Tips

Kraft Heinz Stock Hits 5-Year Low on Berkshire Exit — Negative

BRK-A  BRK-B  KHC   Schaeffers Research — January 21, 2026

Kraft Heinz Co (NASDAQ:KHC) stock is down 7% to trade at $22.07 at last check, following news that Berkshire Hathaway -- the company's biggest shareholder -- could sell nearly all of its shares.

image for news Kraft Heinz Stock Hits 5-Year Low on Berkshire Exit

Gold up, but off early record high as Trump won't forcibly take Greenland — Neutral

AAAU  BAR  DBP  DGL  GLD  GLDM  IAU  OUNZ  SGOL  UGL   Kitco — January 21, 2026

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

image for news Gold up, but off early record high as Trump won't forcibly take Greenland

TE Connectivity plc (TEL) Q1 2026 Earnings Call Transcript — Neutral

TEL   Seeking Alpha — January 21, 2026

TE Connectivity plc (TEL) Q1 2026 Earnings Call Transcript

image for news TE Connectivity plc (TEL) Q1 2026 Earnings Call Transcript

Reasons Why You Should Retain Fiserv Stock in Your Portfolio — Positive

FISV   Zacks Investment Research — January 21, 2026

FISV is leveraging SaaS adoption, upgraded payment platforms and strategic acquisitions to drive steady revenue growth in 2026.

image for news Reasons Why You Should Retain Fiserv Stock in Your Portfolio

GSK to Boost Respiratory & Immunology Pipeline With $2.2B RAPT Buyout — Positive

GSK  RAPT   Zacks Investment Research — January 21, 2026

GSK agrees to buy RAPT Therapeutics for $2.2B, adding ozureprubart to its pipeline and strengthening its respiratory and immunology portfolio.

image for news GSK to Boost Respiratory & Immunology Pipeline With $2.2B RAPT Buyout

Precious Metal ETF (DBP) Hits New 52-Week High — Negative

DBP   Zacks Investment Research — January 21, 2026

DBP hits a 52-week high, up nearly 89% from its low as gold and silver rally amid geopolitical uncertainty and renewed trade tensions.

image for news Precious Metal ETF (DBP) Hits New 52-Week High

nLIGHT: Riding The Market Dynamics For Sustainable Growth — Positive

LASR   Seeking Alpha — January 21, 2026

nLIGHT, Inc. is rated a buy, driven by robust A&D revenue growth and strong positioning in the rapidly expanding directed energy weapons market. LASR's Q3 2025 revenue grew 19% YoY to $66.7M, with A&D sales reaching a record $45.6M, now 68% of total revenue. Key DoD contracts, including a $171M award and 50Kw-class HEL delivery, underpin forward visibility and justify bullish expectations for Q4 2025 and beyond.

image for news nLIGHT: Riding The Market Dynamics For Sustainable Growth

UnitedHealth to offer rebates to its Obamacare customers — Positive

UNH   Reuters — January 21, 2026

UnitedHealth Group Inc. will provide rebates to its Obamacare plan members in 2026, company CEO Stephen Hemsley said in a prepared testimony released Wednesday.

image for news UnitedHealth to offer rebates to its Obamacare customers